Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026)
Alpha Tau Medical (DRTS) posted Other Non-Current Liabilities of $5.4 million for Q4 2025, up 41.6% sequentially from $3.8 million in Q2 2025, and up 60.4% YoY from $3.3 million in Q4 2024.
Analysis
Alpha Tau Medical (DRTS) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Alpha Tau Medical has reported Other Non-Current Liabilities for 6 years, with the latest figure at $5.4 million in Q4 2025.
- Quarterly Other Non-Current Liabilities rose 60.4% year-over-year to $5.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.4 million (up 60.4% YoY) and the FY2025 annual result came in at $5.4 million, up 60.4% from the prior year.
- Other Non-Current Liabilities improved to $5.4 million in Q4 2025 per DRTS's latest filing, from $3.8 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $18.6 million in Q4 2021 and troughed at $977000.0 in Q4 2023.
- A 5-year average of $7.1 million and a median of $4.1 million in 2024 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities surged 247.06% in 2021, then slumped 88.04% in 2022.
- Over 5 years, Other Non-Current Liabilities stood at $18.6 million in 2021, then plunged by 88.04% to $2.2 million in 2022, then plunged by 56.15% to $977000.0 in 2023, then surged by 241.66% to $3.3 million in 2024, then surged by 60.4% to $5.4 million in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.4 million, $3.8 million, and $3.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Alpha Tau Medical | 1.21 Bn | 1.11 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.54 Mn |
| Mar 31, 2026 | 15.75 Mn |
| Dec 31, 2025 | 5.35 Mn |
| Sep 30, 2025 | 5.43 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 3.55 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Sep 30, 2024 | 3.44 Mn |
| Jun 30, 2024 | 4.06 Mn |
| Mar 31, 2024 | 4.49 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 5.44 Mn |
| Jun 30, 2023 | 7.79 Mn |
| Mar 31, 2023 | 5.93 Mn |
| Dec 31, 2022 | 5.63 Mn |
| Sep 30, 2022 | 8.76 Mn |
| Jun 30, 2022 | 12.95 Mn |
| Mar 31, 2022 | 18.76 Mn |
| Dec 31, 2021 | 18.62 Mn |
| Mar 31, 2021 | 8.46 Mn |